Is Tau Acetylation a Key to Frontotemporal Lobar Degeneration Diagnosis?
Clin Chem. 2026 Jul 27:hvag090. doi: 10.1093/clinchem/hvag090. Online ahead of print. NO ABSTRACT PMID:42504910 | DOI:10.1093/clinchem/hvag090

Clin Chem. 2026 Jul 27:hvag090. doi: 10.1093/clinchem/hvag090. Online ahead of print. NO ABSTRACT PMID:42504910 | DOI:10.1093/clinchem/hvag090
Clin Chem. 2026 Jul 17:hvag085. doi: 10.1093/clinchem/hvag085. Online ahead of print. NO ABSTRACT PMID:42467676 | DOI:10.1093/clinchem/hvag085
Clin Chem. 2026 Jul 17:hvag082. doi: 10.1093/clinchem/hvag082. Online ahead of print. ABSTRACT BACKGROUND: Cardiac myosin binding protein C (cMyC) is a cardiac-specific biomarker that is released after acute ischemic myocardial injury. Cardiac troponins are established cardiac biomarkers of myocardial injury and provide prognostic information in patients with cardiovascular disease (CVD) and in healthy persons from … Read more
Clin Chem. 2026 Jul 15:hvag083. doi: 10.1093/clinchem/hvag083. Online ahead of print. NO ABSTRACT PMID:42455123 | DOI:10.1093/clinchem/hvag083
Clin Chem. 2026 Jul 15:hvag080. doi: 10.1093/clinchem/hvag080. Online ahead of print. ABSTRACT BACKGROUND: Therapeutic monoclonal antibodies (t-mAbs) are widely used in oncology, hematology, and immune-mediated diseases. Some t-mAbs are detectable by serum protein electrophoresis (SPEP) and immunofixation (IF), potentially mimicking monoclonal gammopathies. Despite widespread use, migration profiles of many t-mAbs remain incompletely described. METHODS: Thirty-six … Read more
Clin Chem. 2026 Jul 10:hvag077. doi: 10.1093/clinchem/hvag077. Online ahead of print. ABSTRACT BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease, represents the leading cause of chronic liver disease globally. The increasing prevalence of the metabolic syndrome has driven a parallel rise in MASLD-related morbidity and mortality. Accurate assessment of … Read more
Clin Chem. 2026 Jul 6;72(7):814-816. doi: 10.1093/clinchem/hvag044. NO ABSTRACT PMID:42402346 | DOI:10.1093/clinchem/hvag044
Clin Chem. 2026 Jul 4:hvag078. doi: 10.1093/clinchem/hvag078. Online ahead of print. ABSTRACT BACKGROUND: The quantification of plasma glucagon and oxyntomodulin is important in the assessment of α-cell function, which is impaired in patients with diabetes. We aimed to transfer between laboratories a novel assay that uses liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the sensitive and … Read more
Clin Chem. 2026 Jul 1:hvag079. doi: 10.1093/clinchem/hvag079. Online ahead of print. ABSTRACT BACKGROUND: Comprehensive drug testing (CDT) by liquid chromatography-high-resolution mass spectrometry (LC-HRMS) is a valuable method for evaluating clinical samples for unknown toxicological agents. However, the sensitivity of CDT methods is generally lower than targeted approaches. A novel MS technology, linear ion trap (LIT)-pulsing, … Read more
Clin Chem. 2026 Jun 25:hvag067. doi: 10.1093/clinchem/hvag067. Online ahead of print. ABSTRACT BACKGROUND: How changes in hemoglobin A1c (HbA1c) and continuous glucose monitoring (CGM) metrics track together over time is poorly understood, particularly in type 2 diabetes. We investigated the patterns of change in HbA1c and CGM metrics among older adults with type 2 diabetes. … Read more